Pemetrexed versus gefitinib as a second-line treatment in advanced nonsquamous nonsmall-cell lung cancer patients harboring wild-type EGFR (CTONG0806): a multicenter randomized trial

Zhou, Q. ; Cheng, Y. ; Yang, J.-J. ; Zhao, M.-F. ; Zhang, L. ; Zhang, X.-C. ; Chen, Z.-H. ; Yan, H.-H. ; Song, Y. ; Chen, J.-H. ; Feng, W.-N. ; Xu, C.-R. ; Wang, Z. ; Chen, H.-J. ; Zhong, W.-Z. ; Liu, Y.-P. ; Wu, Y.-L.

Annals of oncology, 2014-12, Vol.25 (12), p.2385-2391 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível